For the Inventor, By the Inventor

Enter assignee name

Calgary, Canada

Zenith Epigenetics Corp.

USPTO Granted Patents = 24

CIPO Patents = 3

EPO Patents = 10

Forward Citations = 225

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

John Frederick Quinn (20 out of 22 patents)

Bryan Cordell Duffy (19 out of 19 patents)

Shuang Liu (18 out of 67 patents)

4. Gregory Scott Martin (16 out of 18 patents)

5. Peter Ronald Young (16 out of 20 patents)

6. Ruifang Wang (15 out of 15 patents)

7. May Xiaowu Jiang (15 out of 20 patents)

8. Gregory Steven Wagner (15 out of 18 patents)

9. He Zhao (8 out of 34 patents)

10. Michael A Ellis (5 out of 19 patents)

11. Bruce Francis Molino (5 out of 41 patents)

12. David John Fairfax (3 out of 10 patents)

13. Vladimir Khlebnikov (2 out of 6 patents)

14. Samuel David Brown (2 out of 4 patents)

15. Olesya Kharenko (2 out of 2 patents)

24 patents: Sort by Forward Citations

1. 12145932 - Method of manufacturing a solid form of a BET bromodomain inhibitor (2024-11-19),

2. 11607405 - Combination therapy for the treatment of triple-negative breast cancer (2023-03-21),

3. 11446306 - Bicyclic bromodomain inhibitors (2022-09-20),

4. 11026926 - Substituted bicyclic compounds as bromodomain inhibitors (2021-06-08),

5. 10772892 - Bicyclic bromodomain inhibitors (2020-09-15),

6. 10710992 - Substituted pyridinones as bromodomain inhibitors (2020-07-14),

7. 10500209 - Quinazolinones as bromodomain inhibitors (2019-12-10),

8. 10363257 - Bicyclic bromodomain inhibitors (2019-07-30),

9. 10292968 - Substituted heterocycles as bromodomain inhibitors (2019-05-21),

10. 10231953 - Inhibitors of bromodomains (2019-03-19),

11. 10226451 - Substituted bicyclic compounds as bromodomain inhibitors (2019-03-12),

12. 10179125 - Substituted pyridines as bromodomain inhibitors (2019-01-15),

13. 10166215 - Substituted bicyclic compounds as bromodomain inhibitors (2019-01-01),

14. 10010556 - Bicyclic bromodomain inhibitors (2018-07-03),

15. 9861637 - Heterocyclic compounds as bromodomain inhibitors (2018-01-09),

Zenith Epigenetics Corp. is a biotechnology company focused on the discovery and development of novel therapeutics for the treatment of cancer and other diseases. With a unique epigenetic platform, the company aims to unlock the potential of epigenetic targets and improve patient outcomes. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

24 Patents

#40 in Calgary

#559 in Canada

#25,860 in the World

Calgary, Canada

Zenith Epigenetics Corp.

Forward Citations = 225

26 inventors:

John Frederick Quinn (20 out of 22 patents)

Bryan Cordell Duffy (19 out of 19 patents)

Shuang Liu (18 out of 67 patents)

4. Gregory Scott Martin (16 out of 18 patents)

5. Peter Ronald Young (16 out of 20 patents)

Please report any incorrect information to support@idiyas.com

Loading…